Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression

Curran, 2012, Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions, J Gene Med, 14, 405, 10.1002/jgm.2604 Brentjens, 2013, CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia, Sci Transl Med, 5, 177ra38, 10.1126/scitranslmed.3005930 Brentjens, 2011, Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias, Blood, 118, 4817, 10.1182/blood-2011-04-348540 Porter, 2011, Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia, N Engl J Med, 365, 725, 10.1056/NEJMoa1103849 Davila, 2014, Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia, Sci Transl Med, 6, 224ra25, 10.1126/scitranslmed.3008226 Vesely, 2011, Natural innate and adaptive immunity to cancer, Annu Rev Immunol, 29, 235, 10.1146/annurev-immunol-031210-101324 Grupp, 2013, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia, N Engl J Med, 368, 1509, 10.1056/NEJMoa1215134 Armitage, 1992, Molecular and biological characterization of a murine ligand for CD40, Nature, 357, 80, 10.1038/357080a0 Schönbeck, 2001, The CD40/CD154 receptor/ligand dyad, Cell Mol Life Sci, 58, 4, 10.1007/PL00000776 Uckun, 1990, Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells, Blood, 76, 2449, 10.1182/blood.V76.12.2449.2449 Gruss, 1995, Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells, Eur J Immunol, 25, 2083, 10.1002/eji.1830250742 Zong, 1991, Nasopharyngeal carcinoma and lymphoinfiltration, Oncology, 48, 290, 10.1159/000226945 Lollini, 1998, Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells, Clin Cancer Res, 4, 1843 van den Oord, 1996, CD40 is a prognostic marker in primary cutaneous malignant melanoma, Am J Pathol, 149, 1953 Wingett, 1998, CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosis, Breast Cancer Res Treat, 50, 27, 10.1023/A:1006012607452 Ciaravino, 2004, Differential expression of CD40 and CD95 in ovarian carcinoma, Eur J Gynaecol Oncol, 25, 27 Altenburg, 1999, CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma, J Immunol, 162, 4140, 10.4049/jimmunol.162.7.4140 Cella, 1996, Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation, J Exp Med, 184, 747, 10.1084/jem.184.2.747 Clarke, 2000, The critical role of CD40/CD40L in the CD4-dependent generation of CD8+ T cell immunity, J Leukoc Biol, 67, 607, 10.1002/jlb.67.5.607 Cayabyab, 1994, CD40 preferentially costimulates activation of CD4+ T lymphocytes, J Immunol, 152, 1523, 10.4049/jimmunol.152.4.1523 Peng, 1996, Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production, Eur J Immunol, 26, 1621, 10.1002/eji.1830260732 Bhadra, 2011, Cutting edge: CD40-CD40 ligand pathway plays a critical CD8-intrinsic and -extrinsic role during rescue of exhausted CD8 T cells, J Immunol, 187, 4421, 10.4049/jimmunol.1102319 Bourgeois, 2002, A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory, Science, 297, 2060, 10.1126/science.1072615 Khong, 2012, The use of agonistic anti-CD40 therapy in treatments for cancer, Int Rev Immunol, 31, 246, 10.3109/08830185.2012.698338 Vonderheide, 2013, Agonistic CD40 antibodies and cancer therapy, Clin Cancer Res, 19, 1035, 10.1158/1078-0432.CCR-12-2064 Wierda, 2000, CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia, Blood, 96, 2917, 10.1182/blood.V96.9.2917 Brentjens, 2003, Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15, Nat Med, 9, 279, 10.1038/nm827 Frentsch, 2013, CD40L expression permits CD8+ T cells to execute immunologic helper functions, Blood, 122, 405, 10.1182/blood-2013-02-483586 Kalos, 2011, T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia, Sci Transl Med, 3, 95ra73, 10.1126/scitranslmed.3002842 Kochenderfer, 2014, Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor, J Clin Oncol Stephan, 2007, T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection, Nat Med, 13, 1440, 10.1038/nm1676 Greaves, 2013, The role of B7 family molecules in hematologic malignancy, Blood, 121, 734, 10.1182/blood-2012-10-385591 Geijtenbeek, 1999, High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia, Blood, 94, 754, 10.1182/blood.V94.2.754 Rieux-Laucat, 1995, Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity, Science, 268, 1347, 10.1126/science.7539157 Schultze, 1995, Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity, Proc Natl Acad Sci USA, 92, 8200, 10.1073/pnas.92.18.8200 Schattner, 1996, CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells, Blood, 88, 1375, 10.1182/blood.V88.4.1375.bloodjournal8841375 O’Neill, 2004, Manipulating dendritic cell biology for the active immunotherapy of cancer, Blood, 104, 2235, 10.1182/blood-2003-12-4392 Higham, 2010, Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand, J Immunol, 184, 3394, 10.4049/jimmunol.0903111 Pegram, 2012, Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning, Blood, 119, 4133, 10.1182/blood-2011-12-400044 Trinchieri, 2003, Interleukin-12 and the regulation of innate resistance and adaptive immunity, Nat Rev Immunol, 3, 133, 10.1038/nri1001 Laurin, 2013, Upregulation of adhesion molecules on leukemia targets improves the efficacy of cytotoxic T cells transduced with chimeric anti-CD19 receptor, J Immunother, 36, 181, 10.1097/CJI.0b013e318288f8c1 Bossen, 2006, Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human, J Biol Chem, 281, 13964, 10.1074/jbc.M601553200 Brown, 1998, Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice, Nat Med, 4, 1253, 10.1038/3233 Di Stasi, 2011, Inducible apoptosis as a safety switch for adoptive cell therapy, N Engl J Med, 365, 1673, 10.1056/NEJMoa1106152 Ghani, 2009, Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media, Hum Gene Ther, 20, 966, 10.1089/hum.2009.001 Ratzinger, 2003, Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation, Blood, 101, 1422, 10.1182/blood-2002-04-1093 Rivière, 1995, Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells, Proc Natl Acad Sci USA, 92, 6733, 10.1073/pnas.92.15.6733 Brentjens, 2007, Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts, Clin Cancer Res, 13, 5426, 10.1158/1078-0432.CCR-07-0674 Gong, 1999, Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen, Neoplasia, 1, 123, 10.1038/sj.neo.7900018 Santos, 2009, Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase, Nat Med, 15, 338, 10.1038/nm.1930 Quintás-Cardama, 2007, Multifactorial optimization of gammaretroviral gene transfer into human T lymphocytes for clinical application, Hum Gene Ther, 18, 1253, 10.1089/hum.2007.088